International Trade Bulletin - Volume 1, Issue 8
Client Alert | 1 min read | 06.26.06
Inside this issue:
- EUROPE IN THE SPOTLIGHT
- CHINA IN THE SPOTLIGHT
- RULES OF ORIGIN: “Made in USA” Marking Update
- ANTI-DUMPING IN THE U.S.: The U.S. Department of Commerce formulates comments submitted in response to the U.S.-adverse WTO Appellate Body Report in United States – Zeroing
- FCPA: U.S. Business Optimism Tempered by Corruption in Southeast Asia
- U.S. SANCTIONS
- INTERNATIONAL IP PROTECTION: Supreme Court Decision Likely to Generate More Intellectual Property Import Protection (Section 337) Cases
- MARKET ACCESS: Korea-U.S. FTA Negotiators Set a Fast Pace in First Round of Negotiations
Contacts
Insights
Client Alert | 4 min read | 01.07.26
On December 17, 2025, the U.S. Food and Drug Administration (FDA) issued a request for information (RFI) on a proposal designed to help the FDA engage more directly with innovative, venture-backed companies focused on biotechnology, medical devices, AI, and regulatory technology.[i]The RFI includes 19 questions, with responses due by 2:00 p.m. ET on January 18, 2026.
Client Alert | 3 min read | 01.07.26
CMMC for AI? Defense Policy Law Imposes AI Security Framework and Requirements on Contractors
Client Alert | 3 min read | 01.07.26
New Year, Same CIPA Uncertainty – When Will the Appellate Courts Enter the Chat?
Client Alert | 11 min read | 01.07.26
